Thanks for that info, really interesting piece of knowledge. So any overseas operation involving OrthoATI/ACI will require a fair amount of capital to get it up any running, how much might that be and will their current cash reserves run to it ?? What sort of time frame might the company be looking at post approvals before they look to establish a facility. Remplir and Striate obviously being the first two cabs off the rank.
Stem Cell Therapy advancements, page-467
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.015(3.90%) |
Mkt cap ! $77.54M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 38.8¢ | 37.0¢ | $47.36K | 125.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 77604 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 17571 | 3 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |